Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ingenol Mebutate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Risks of Picato for actinic keratosis outweigh benefits
    Risks of Picato for actinic keratosis outweigh benefits

    30 Apr 2020

    // EMA

    https://www.ema.europa.eu/en/news/risks-picato-actinic-keratosis-outweigh-benefits

    EMA
    30 Apr 2020
    Share Share
    EMA confirms skin cancer risk with LEO's Picato
    EMA confirms skin cancer risk with LEO's Picato

    20 Apr 2020

    // Selina McKee PHARMATIMES

    http://www.pharmatimes.com/news/ema_confirms_skin_cancer_risk_with_leos_picato_1338594

    Selina McKee PHARMATIMES
    20 Apr 2020
    Share Share
    EMA Begins Publishing All Health Professional Communications
    EMA Begins Publishing All Health Professional Communications

    14 Feb 2020

    // Michael Mezher RAPS

    https://www.raps.org/news-and-articles/news-articles/2020/2/ema-begins-publishing-all-health-professional-comm

    Michael Mezher RAPS
    14 Feb 2020
    Share Share
    Ingenol mebutate gel: suspension of the licence due to risk of skin malignancy
    Ingenol mebutate gel: suspension of the licence due to risk of skin malignancy

    13 Feb 2020

    // GOVUK

    https://www.gov.uk/drug-safety-update/ingenol-mebutate-gel-picato-suspension-of-the-licence-due-to-risk-of-skin-malignancy

    GOVUK
    13 Feb 2020
    Share Share
    LEO issues Picato recall
    LEO issues Picato recall

    01 Feb 2020

    // Anna Smith PHARMA TIMES

    http://www.pharmatimes.com/news/leo_issues_picato_recall_1323880

    Anna Smith PHARMA TIMES
    01 Feb 2020
    Share Share
    EMA suspends Picato as a precaution while review of skin cancer risk continue
    EMA suspends Picato as a precaution while review of skin cancer risk continue

    18 Jan 2020

    // EMA

    https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-13-16-january-2020

    EMA
    18 Jan 2020
    Share Share